The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 14, 2025

Filed:

Jul. 01, 2022
Applicants:

David L. Burge, Flat Rock, NC (US);

Catherine M. Burge, Flat Rock, NC (US);

Inventors:

David L. Burge, Flat Rock, NC (US);

Catherine M. Burge, Flat Rock, NC (US);

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61F 7/02 (2006.01); A41D 31/04 (2019.01); A61F 7/08 (2006.01); A61N 5/06 (2006.01);
U.S. Cl.
CPC ...
A61F 7/02 (2013.01); A61F 7/08 (2013.01); A41D 2400/10 (2013.01); A41D 2400/32 (2013.01); A61F 2007/0233 (2013.01); A61F 2007/0266 (2013.01); A61F 2007/0282 (2013.01); D10B 2321/10 (2013.01); D10B 2509/00 (2013.01);
Abstract

The present invention relates generally to therapeutic articles comprised of carbonaceous blend textile materials comprising yarns having about 25 to 100 weight % carbonaceous fiber and about 0 to 75 weight % fiber made of polyester, nylon, rayon, lyocell, cellulose, wool, silk, linen, bamboo, m-aramid, p-aramid, modacrylic, novoloid, melamine, regenerated cellulose, polyvinyl chloride, antistatic fiber, poly(p-phenylene benzobisoxazole) (PBO), polybenzimidazole (PBI), polysulphonamide (PSA), and combinations thereof, or other fibers not listed that are capable of being made into yarn and textile fabrics that are knit, woven, or nonwoven, and wherein the fabric has a weight from about 3 oz/ydto about 20 oz/yd. Also encompassed within this invention is a method for using therapeutic textile articles having carbonaceous blend textile materials of the present disclosure for treatment of humans and animals with developmental neurological disorders, central nervous system disorders, autoimmune disorders, cardiovascular disease, sleep disorders, anxiety disorders, pain management, and diabetes.


Find Patent Forward Citations

Loading…